Precursor B-cell development in bone marrow of Good syndrome patients

Clin Immunol. 2019 Mar:200:39-42. doi: 10.1016/j.clim.2018.11.009. Epub 2019 Jan 25.

Abstract

Good syndrome is an immunodeficiency presenting with thymoma, hypogammaglobulinemia and almost absent B cells. To investigate the origin of the B-cell lymphopenia in these patients, we studied B cell differentiation in the bone marrow of Good syndrome patients. We found very low numbers of precursor B cells in bone marrow of Good syndrome patients and a differentiation arrest after the pro-B-cell stage; this is different from other agammaglobulinemia patients with a defect in pre B-cell receptor signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agammaglobulinemia / complications
  • Agammaglobulinemia / immunology*
  • Agammaglobulinemia / therapy
  • Aged
  • Anti-Infective Agents / therapeutic use
  • B-Lymphocytes / cytology*
  • B-Lymphocytes / immunology
  • Bone Marrow*
  • Female
  • Humans
  • Immunoglobulins / therapeutic use
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunologic Deficiency Syndromes / immunology
  • Immunologic Deficiency Syndromes / therapy
  • Immunologic Factors / therapeutic use
  • Lymphopenia / complications
  • Lymphopenia / immunology*
  • Lymphopenia / therapy
  • Lymphopoiesis / immunology*
  • Male
  • Middle Aged
  • Precursor Cells, B-Lymphoid / cytology*
  • Precursor Cells, B-Lymphoid / immunology
  • Syndrome
  • Thymectomy
  • Thymoma / complications
  • Thymoma / immunology*
  • Thymoma / therapy
  • Thymus Neoplasms / complications
  • Thymus Neoplasms / immunology*
  • Thymus Neoplasms / therapy

Substances

  • Anti-Infective Agents
  • Immunoglobulins
  • Immunoglobulins, Intravenous
  • Immunologic Factors